Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Flow Cytometry01:23

Flow Cytometry

12.9K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
12.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Should flow cytometry be required for CMML diagnosis? Position of the ELN iMDS Flow Working Group.

HemaSphere·2026
Same author

Adult <i>TWIST2</i>-high B-ALL confirms metabolic association but reveals molecular heterogeneity.

HemaSphere·2026
Same author

A practical approach to risk stratification of incidental T cell clonality.

Blood advances·2026
Same author

Comprehensive landscape of secondary cytogenetic and molecular genetic events in multiple myeloma patients at diagnosis.

Leukemia·2026
Same author

SIRT6-Mediated Deacetylation of ATF3 Promotes Silica-Induced Lung Fibrosis by Enhancing its Nuclear Import via Binding to Importin α.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Insights into the Micronutrient and Cardiovascular Health Risks during Pregnancy.

The Journal of nutrition·2026

相关实验视频

Updated: Jun 27, 2025

Flow Cytometric Analysis of Bimolecular Fluorescence Complementation: A High Throughput Quantitative Method to Study Protein-protein Interaction
11:11

Flow Cytometric Analysis of Bimolecular Fluorescence Complementation: A High Throughput Quantitative Method to Study Protein-protein Interaction

Published on: August 15, 2013

18.4K

流细胞测量中的TRBC1:测试开发,验证和报告考虑.

Katherine A Devitt1,2, Wolfgang Kern3, Weijie Li4

  • 1Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.

Cytometry. Part B, Clinical cytometry
|May 3, 2024
PubMed
概括

T细胞受体常数区域1 (TRBC1) 标记物在临床流细胞计中显著改善了T细胞瘤的诊断. 本研究指导其整合到现有的面板和解释,以准确评估T细胞克隆性.

关键词:
这就是T细胞的特征.流动细胞计量是流动细胞计量的方法.这种白血病是白血病.淋巴瘤淋巴瘤是什么验证验证的时间

更多相关视频

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

15.7K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.0K

相关实验视频

Last Updated: Jun 27, 2025

Flow Cytometric Analysis of Bimolecular Fluorescence Complementation: A High Throughput Quantitative Method to Study Protein-protein Interaction
11:11

Flow Cytometric Analysis of Bimolecular Fluorescence Complementation: A High Throughput Quantitative Method to Study Protein-protein Interaction

Published on: August 15, 2013

18.4K
Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

15.7K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.0K

科学领域:

  • 免疫学 免疫学 免疫学
  • 血液病理学 血液病理学
  • 临床细胞计量是指临床细胞计量.

背景情况:

  • 通过流式细胞计量对T细胞克隆性进行评估,传统上依赖于非最佳的方法,如异常标记物表达.
  • 准确诊断T细胞新生瘤对于有效的患者治疗和管理至关重要.

研究的目的:

  • 引入T细胞受体常数区域1 (TRBC1) 作为T细胞瘤诊断的有希望的标记物.
  • 提供关于将TRBC1纳入T细胞处理的现有流细胞计画面板的指导.
  • 提供案例,并突出例行临床应用的潜在解释挑战.

主要方法:

  • 审查TRBC1标记物质及其在流细胞计中的应用.
  • 开发和介绍将TRBC1集成到已建立的T细胞面板中的策略.
  • 对例证研究的分析,说明TRBC1的实用性和诊断方面的考虑.

主要成果:

  • TRBC1显示出显著的潜力,可以提高T细胞瘤的诊断准确性.
  • 将其集成到现有面板中是可行的,并提供了实践示例.
  • 确定了需要谨慎解释TRBC1结果的特定诊断场景.

结论:

  • 在临床流细胞计量中,TRBC1是改进T细胞克隆性评估的宝贵工具.
  • 适当的整合和解释是最大限度地提高其诊断实用性的关键.
  • 建议流细胞计社区对TRBC1进行进一步的熟悉.